Company Filing History:
Years Active: 2008
Title: Jan Wisniewski: Innovator in Retinoic Acid Metabolism
Introduction
Jan Wisniewski is a notable inventor based in Harrowsmith, Canada. He has made significant contributions to the field of biochemistry, particularly in the area of retinoic acid metabolism. His work has implications for cancer treatment, showcasing the potential of innovative approaches in medical science.
Latest Patents
Wisniewski holds a patent for a novel retinoic acid metabolizing cytochrome P450, known as P450RAI-3. This enzyme is predominantly expressed in the adrenal gland and plays a crucial role in the metabolism of retinoic acid. The patent outlines methods and uses of the new polynucleotide, polypeptide, and their fragments, as well as modulators, which can be utilized in cancer treatment. He has 1 patent to his name, reflecting his innovative contributions to the field.
Career Highlights
Jan Wisniewski is associated with Cytochroma Inc., a company focused on developing novel therapeutic solutions. His work at the company emphasizes the importance of research and innovation in addressing complex health issues. His expertise in biochemistry and pharmacology has positioned him as a valuable asset in the scientific community.
Collaborations
Wisniewski has collaborated with notable colleagues, including Martin Petkovich and Heather Ramshaw. These partnerships highlight the collaborative nature of scientific research, where diverse expertise contributes to groundbreaking discoveries.
Conclusion
Jan Wisniewski's work in retinoic acid metabolism represents a significant advancement in the field of biochemistry. His innovative patent and collaborations underscore the importance of research in developing new treatments for cancer. His contributions continue to inspire future innovations in medical science.